Fig. 6From: Sorafenib and docosahexaenoic acid act in synergy to suppress cancer cell viability: a role of heme oxygenase 1Sorafenib and DHA act together to suppress xenograft tumor growth. MDA-MB-231 cells were implanted into the flanks of nude mice fed either an n-3 or n-6 enriched diet. The xenograft tumor growth, indicated by tumor volume, in mice that were treated either with the vehicle alone (a) or with Sorafenib (b) are shown (n = 5, means ± SEM, *p < 0.01)Back to article page